|
|
|
|
|
|
By Natalie Farris, Naltou Pharma CMC Consulting LLC | When viewing a CDMO as merely a service provider, interactions are often limited to completing tasks. This mindset can stifle innovation and problem-solving. | |
|
|
|
| Getting To The Heart Of CDMO Tech Transfer Excellence | Article | Bora Pharmaceuticals | Discover five key factors that drive a seamless and efficient technology transfer and learn why a culture of technical expertise, customer focus, and flexibility is crucial to success in the CDMO industry. |
|
|
| Does Your CDMO Have An Analytical Edge? | Article | By Anna Małecka and Paulina Toboła, Mabion | Due to the complexity of biologics, precise analytical technology is crucial throughout every phase of drug development to ensure the highest standards of quality, safety, and regulatory compliance. |
|
|
|
|
|
|
|
|
| Multispecific molecules bring added complexity to downstream purification—think incorrect chain pairings, aggregation, fragmentation, and lower yields. Join Bioprocess Online Live as we explore how developers are addressing these challenges to achieve high purity and efficient processes. Gain insights into key considerations for downstream teams when designing purification strategies for these advanced biologics. Registration is free thanks to the support of Thermo Fisher Scientific. |
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
